Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 1, 2009, Pages 48-52

  Miederer, Matthias ^a   Seidl, Stefan ^a   Buck, Andreas ^a   Scheidhauer, Klemens ^a   Wester, Hans Jürgen ^a   Schwaiger, Markus ^a   Perren, Aurel ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

68Ga DOTATOC; Endocrine oncology; PET CT; Receptor imaging; Somatostatin Receptor; SSTR2 Immunohistochemistry

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID OCTREOTIDE[3 TYROSINE] GA 68; OCTREOTIDE[3 TYROSINE]; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IN VIVO STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD;

ADULT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEUROENDOCRINE TUMORS; OCTREOTIDE; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, SOMATOSTATIN; RETROSPECTIVE STUDIES; THYMOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 57249095880     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0944-5     Document Type: Article

References (10)

1. EP Krenning R Valkema DJ Kwekkeboom WW de Herder CH van Eijck M de Jong S Pauwels JC Reubi 2005 Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapy J Nucl Med 46 Suppl 1 76S 82S
2. DJ Kwekkeboom EP Krenning 1997 Radiolabeled somatostatin analog scintigraphy in oncology and immune diseases: an overview Eur Radiol 7 7 1103 9
3. AJ van der Lely WW de Herder EP Krenning DJ Kwekkeboom 2003 Octreoscan radioreceptor imaging Endocrine 20 3 307 11
4. P Antunes M Ginj H Zhang B Waser RP Baum JC Reubi H Maecke 2007 Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging 34 7 982 93
5. JC Reubi JC Schar B Waser S Wenger A Heppeler JS Schmitt HR Macke 2000 Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use Eur J Nucl Med 27 3 273 82
6. T Steinmuller R Kianmanesh M Falconi A Scarpa B Taal DJ Kwekkeboom JM Lopes A Perren G Nikou J Yao 2008 Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary Neuroendocrinology 87 1 47 62
7. I Buchmann M Henze S Engelbrecht M Eisenhut A Runz M Schafer T Schilling S Haufe T Herrmann U Haberkorn 2007 Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours Eur J Nucl Med Mol Imaging 34 10 1617 26
8. M Volante MP Brizzi A Faggiano S La Rosa I Rapa A Ferrero G Mansueto L Righi S Garancini C Capella 2007 Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy Mod Pathol 20 11 1172 82
9. A Asnacios F Courbon P Rochaix E Bauvin V Cances-Lauwers C Susini S Schulz A Boneu R Guimbaud L Buscail 2008 Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors J Clin Oncol 26 6 963 70
10. H Wieder AJ Beer T Poethko G Meisetschlaeger HJ Wester E Rummeny M Schwaiger AR Stahl 2008 PET/CT with Gluc-Lys-([(18)F]FP)-TOCA: correlation between uptake, size and arterial perfusion in somatostatin receptor positive lesions Eur J Nucl Med Mol Imaging 35 2 264 71